Tokyo Tape
Sign in
← Ain Holdings

Quarterly report · Q1

9627.TEDINET S100RUX5
Period2023-05-01 → 2023-07-31
Filed2023-09-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
MetricValuePeriodScopeSource row
Revenue¥94.7bn2023-05-01 → 2023-07-31Cons.Net sales
Revenue¥358.7bn2022-05-01 → 2023-04-30Cons.Net sales (5-year summary)
Revenue¥81.5bn2022-05-01 → 2022-07-31Cons.Net sales
Operating income¥3.6bn2023-05-01 → 2023-07-31Cons.Operating income
Operating income¥2.8bn2022-05-01 → 2022-07-31Cons.Operating income
Ordinary income¥3.9bn2023-05-01 → 2023-07-31Cons.Ordinary income
Ordinary income¥17.1bn2022-05-01 → 2023-04-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥3.1bn2022-05-01 → 2022-07-31Cons.Ordinary income
Profit before tax¥3.9bn2023-05-01 → 2023-07-31Cons.Income before income taxes
Profit before tax¥3.0bn2022-05-01 → 2022-07-31Cons.Income before income taxes
Net income (owners)¥2.1bn2023-05-01 → 2023-07-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥9.2bn2022-05-01 → 2023-04-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥1.7bn2022-05-01 → 2022-07-31Cons.Profit loss attributable to owners of parent
Net income¥2.1bn2023-05-01 → 2023-07-31Cons.Profit loss
Net income¥1.7bn2022-05-01 → 2022-07-31Cons.Profit loss
Total assets¥235.6bnat 2023-07-31Cons.Assets
Total assets¥231.8bnat 2023-04-30Cons.Assets
Total assets¥228.6bnat 2022-07-31Cons.Total assets (5-year summary)
Total liabilities¥109.0bnat 2023-07-31Cons.Liabilities
Total liabilities¥105.2bnat 2023-04-30Cons.Liabilities
Net assets / equity¥126.6bnat 2023-07-31Cons.Net assets
Net assets / equity¥126.5bnat 2023-04-30Cons.Net assets
Net assets / equity¥118.8bnat 2022-07-31Cons.Net assets (5-year summary)
Cash and deposits¥47.4bnat 2023-07-31Cons.Cash and deposits
Cash and deposits¥46.8bnat 2023-04-30Cons.Cash and deposits
EPS (basic)¥60.932023-05-01 → 2023-07-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥262.872022-05-01 → 2023-04-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥48.542022-05-01 → 2022-07-31Cons.Basic earnings loss per share (5-year summary)
Equity ratio53.7%at 2023-07-31Cons.Equity to asset ratio (5-year summary)
Equity ratio54.6%at 2023-04-30Cons.Equity to asset ratio (5-year summary)
Equity ratio51.9%at 2022-07-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 34
SegmentItemPeriodValue
Otherother segmentsrevenue2023-05-01 → 2023-07-31¥2.8bn
Otherother segmentsrevenue external2023-05-01 → 2023-07-31¥2.8bn
Otherother segmentsrevenue intersegment2023-05-01 → 2023-07-31¥12m
Otherother segmentssegment ordinary income2023-05-01 → 2023-07-31−¥5m
Reconciling Itemsreconcilingrevenue2023-05-01 → 2023-07-31−¥12m
Reconciling Itemsreconcilingrevenue intersegment2023-05-01 → 2023-07-31−¥12m
Reconciling Itemsreconcilingsegment ordinary income2023-05-01 → 2023-07-31−¥2.3bn
jpcrp040300-q1r_E04896-000Dispensing Pharmacyreportable segmentrevenue2023-05-01 → 2023-07-31¥84.4bn
jpcrp040300-q1r_E04896-000Dispensing Pharmacyreportable segmentrevenue external2023-05-01 → 2023-07-31¥84.4bn
jpcrp040300-q1r_E04896-000Dispensing Pharmacyreportable segmentsegment ordinary income2023-05-01 → 2023-07-31¥5.4bn
jpcrp040300-q1r_E04896-000Drug And Cosmetic Storereportable segmentrevenue2023-05-01 → 2023-07-31¥7.4bn
jpcrp040300-q1r_E04896-000Drug And Cosmetic Storereportable segmentrevenue external2023-05-01 → 2023-07-31¥7.4bn
jpcrp040300-q1r_E04896-000Drug And Cosmetic Storereportable segmentsegment ordinary income2023-05-01 → 2023-07-31¥710m
—segment totalrevenue2023-05-01 → 2023-07-31¥94.7bn
—segment totalrevenue external2023-05-01 → 2023-07-31¥94.7bn
—segment totalrevenue intersegment2023-05-01 → 2023-07-31¥12m
—segment totalsegment ordinary income2023-05-01 → 2023-07-31¥6.1bn
Otherother segmentsrevenue2022-05-01 → 2022-07-31¥2.9bn
Otherother segmentsrevenue external2022-05-01 → 2022-07-31¥2.9bn
Otherother segmentsrevenue intersegment2022-05-01 → 2022-07-31¥18m
Otherother segmentssegment ordinary income2022-05-01 → 2022-07-31¥4m
Reconciling Itemsreconcilingrevenue2022-05-01 → 2022-07-31−¥18m
Reconciling Itemsreconcilingrevenue intersegment2022-05-01 → 2022-07-31−¥18m
Reconciling Itemsreconcilingsegment ordinary income2022-05-01 → 2022-07-31−¥1.8bn
jpcrp040300-q1r_E04896-000Dispensing Pharmacyreportable segmentrevenue2022-05-01 → 2022-07-31¥72.5bn
jpcrp040300-q1r_E04896-000Dispensing Pharmacyreportable segmentrevenue external2022-05-01 → 2022-07-31¥72.5bn
jpcrp040300-q1r_E04896-000Dispensing Pharmacyreportable segmentsegment ordinary income2022-05-01 → 2022-07-31¥4.7bn
jpcrp040300-q1r_E04896-000Drug And Cosmetic Storereportable segmentrevenue2022-05-01 → 2022-07-31¥6.1bn
jpcrp040300-q1r_E04896-000Drug And Cosmetic Storereportable segmentrevenue external2022-05-01 → 2022-07-31¥6.1bn
jpcrp040300-q1r_E04896-000Drug And Cosmetic Storereportable segmentsegment ordinary income2022-05-01 → 2022-07-31¥164m
—segment totalrevenue2022-05-01 → 2022-07-31¥81.5bn
—segment totalrevenue external2022-05-01 → 2022-07-31¥81.5bn
—segment totalrevenue intersegment2022-05-01 → 2022-07-31¥18m
—segment totalsegment ordinary income2022-05-01 → 2022-07-31¥4.9bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 369
ItemContextValueUnit
Impairment loss elPrior1YTDDuration20000000JPY
Impairment loss elCurrentYTDDuration139000000JPY
Other elPrior1YTDDuration11000000JPY
Other elCurrentYTDDuration6000000JPY
Extraordinary lossPrior1YTDDuration98000000JPY
Extraordinary lossCurrentYTDDuration216000000JPY
Income before income taxesPrior1YTDDuration2997000000JPY
Income before income taxesCurrentYTDDuration3942000000JPY
Income taxesPrior1YTDDuration1293000000JPY
Income taxesCurrentYTDDuration1805000000JPY
Profit lossPrior1YTDDuration1704000000JPY
Profit lossCurrentYTDDuration2136000000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration-0JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration-3000000JPY
Profit loss attributable to owners of parentPrior1YTDDuration1704000000JPY
Profit loss attributable to owners of parentCurrentYTDDuration2140000000JPY
Profit lossPrior1YTDDuration1704000000JPY
Profit lossCurrentYTDDuration2136000000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration-14000000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration50000000JPY
Remeasurements of defined benefit plans net of tax ociPrior1YTDDuration6000000JPY
Remeasurements of defined benefit plans net of tax ociCurrentYTDDuration-7000000JPY
Other comprehensive incomePrior1YTDDuration-8000000JPY
Other comprehensive incomeCurrentYTDDuration42000000JPY
Comprehensive incomePrior1YTDDuration1695000000JPY
Comprehensive incomeCurrentYTDDuration2179000000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration1696000000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration2183000000JPY
Comprehensive income attributable to non controlling interestsPrior1YTDDuration-0JPY
Comprehensive income attributable to non controlling interestsCurrentYTDDuration-3000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q1r_E04896-000DispensingPharmacyReportableSegmentsMember72482000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q1r_E04896-000DrugAndCosmeticStoreReportableSegmentsMember6086000000JPY
Revenues from external customersPrior1YTDDuration_OtherReportableSegmentsMember2901000000JPY
Revenues from external customersPrior1YTDDuration_ReportableSegmentsMember81470000000JPY
Revenues from external customersPrior1YTDDuration_ReconcilingItemsMember－JPY
Revenues from external customersPrior1YTDDuration81470000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q1r_E04896-000DispensingPharmacyReportableSegmentsMember－JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q1r_E04896-000DrugAndCosmeticStoreReportableSegmentsMember－JPY
Transactions with other segmentsPrior1YTDDuration_OtherReportableSegmentsMember18000000JPY
Transactions with other segmentsPrior1YTDDuration_ReportableSegmentsMember18000000JPY
Transactions with other segmentsPrior1YTDDuration_ReconcilingItemsMember-18000000JPY
Transactions with other segmentsPrior1YTDDuration－JPY
Net salesPrior1YTDDuration_jpcrp040300-q1r_E04896-000DispensingPharmacyReportableSegmentsMember72482000000JPY
Net salesPrior1YTDDuration_jpcrp040300-q1r_E04896-000DrugAndCosmeticStoreReportableSegmentsMember6086000000JPY
Net salesPrior1YTDDuration_OtherReportableSegmentsMember2920000000JPY
Net salesPrior1YTDDuration_ReportableSegmentsMember81489000000JPY
Net salesPrior1YTDDuration_ReconcilingItemsMember-18000000JPY
Net salesPrior1YTDDuration81470000000JPY
Ordinary incomePrior1YTDDuration_jpcrp040300-q1r_E04896-000DispensingPharmacyReportableSegmentsMember4732000000JPY
Ordinary incomePrior1YTDDuration_jpcrp040300-q1r_E04896-000DrugAndCosmeticStoreReportableSegmentsMember164000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-04-30pass
balance sheet identityconsolidated 2023-07-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-04-30pass
statement vs summary · net assetsconsolidated 2023-07-31pass
statement vs summary · net income attributable to parentconsolidated 2022-05-01/2022-07-31pass
statement vs summary · net income attributable to parentconsolidated 2023-05-01/2023-07-31pass
statement vs summary · revenueconsolidated 2022-05-01/2022-07-31pass
statement vs summary · revenueconsolidated 2023-05-01/2023-07-31pass
statement vs summary · total assetsconsolidated 2023-04-30pass
statement vs summary · total assetsconsolidated 2023-07-31pass